The Pharma Career Ladder · The country manager · Step 1: Setting strategy · Lesson 3

Reading your portfolio honestly

Stars, cash cows, question marks, dogs

By Ahmed El Menshawy · 20 years in pharma, from medical rep to country manager in the UAE. Founder of RepPharma. LinkedIn
Published

Most leadership teams can recite their portfolio brand by brand.

Fewer will say out loud which brands pay for the plan and which only consume it.

The BCG growth-share matrix is decades old and still one of the most useful hours a country team can spend. Two questions per brand: how fast is its segment growing, and how strong is our share in it?

  • Stars. High share, growing segment. Invest to hold the lead.
  • Cash cows. High share, slow segment. Protect them and spend carefully. They fund everything else.
  • Question marks. Low share, growing segment. Back them properly or step back. Half-backing is the expensive option.
  • Dogs. Low share, slow segment. Keep them lean, or plan the exit.

The model is simple. The difficulty is human. Everyone in the room has a brand they launched, defended or grew up with.

Three habits that help, in my experience:

  • Place each brand by where its segment is going, not by its history.
  • Judge share on sell-out and market data. Sell-in tells you what the distributor bought, not what pharmacies and hospitals ordered.
  • Once the boxes are agreed, tell the team what each box gets in people and budget.
“The matrix is easy. Being honest about your favourite brand is not.”
Reading your portfolio honestly: Stars, cash cows, question marks, dogs

Lesson 3 of 16 in Step 1: Setting strategy, with the full guide and a checklist for this week.

More lessons in step 1: Setting strategy

Setting strategy, in RepPharma

Targets split by rep, product and month

Yearly targets are split by rep, product and month, and sales credit can be moved between reps without changing the company total.

Distributor stock and sell-out

Distributor stock and pharmacy sell-out side by side, with short-expiry lots flagged up to 90 days ahead.

One system for the whole field force

Visits, plans, forecasts, samples, expenses, leaves and approvals, with role-based access from rep to country manager.

A new step every week in the Pharma Career Ladder newsletter on LinkedIn.